Veterinary Antimicrobial Susceptibility Testing Market Size, Share & Trends Analysis Report By Product (2026-2034) (Disks & Plates, Culture Media, Accessories & Consumables, Automated AST Instruments), By Animal Type (2026-2034) (Production Animal, Cattle, Poultry, Pigs, Others, Companion Animal, Dogs, Cats, Horses), By End Use (2026-2034) (Veterinary Reference Lab, Vet Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Veterinary Antimicrobial Susceptibility Testing Market Size & Growth Analysis

The global veterinary antimicrobial susceptibility testing market size was valued at USD 1.22 billion in 2025 and is projected to grow from USD 1.32 billion in 2026 to USD 2.43 billion by 2034, registering a CAGR of 7.97% during the forecast period from 2026 to 2034. North America dominated the veterinary antimicrobial susceptibility testing market with a market share of 35.11% in 2025.

The veterinary antimicrobial susceptibility testing market encompasses diagnostic solutions used to determine the effectiveness of antimicrobial agents against animal pathogens. It includes products such as disks and plates, culture media, consumables, and automated AST instruments, applied across production animals, including cattle, poultry, and pigs, as well as companion animals. These solutions are utilized by veterinary reference laboratories, research institutes, and other animal health facilities.

Product Insights

The automated AST instruments segment dominated the market in 2025, accounting for 42.94% revenue share, owing to the increased integration of AI‑driven image analysis that automates zone diameter interpretation and MIC determination, reducing subjective variability and enabling smaller veterinary labs to achieve standardized susceptibility results with minimal specialist oversight.

The disks & plates segment is estimated to register the fastest CAGR of 8.35% during the forecast period. This growth is fuelled by the adoption of chromogenic and selective agar plates designed specifically for differentiating resistant veterinary pathogens, which improves interpretive clarity and reduces retesting.

Request Customizationto receive a tailored report.

Animal Type Insights

The production animal segment dominated the market and accounted for the highest revenue share in 2025. This growth is attributed to the mandated integration of pathogen-specific AST profiling for export certification of livestock products, where countries like Brazil require detailed antimicrobial resistance documentation for poultry and swine shipments to the EU, directly boosting routine AST adoption in commercial herds.

The companion animal segment is projected to register the fastest CAGR of 8.14% during the forecast timeframe, owing to the increasing implementation of standardized pre‑antibiotic culture and susceptibility panels for frequent canine and feline infections in small animal practices, driven by updated clinical guidelines.

End Use Insights

The veterinary reference lab segment dominated the market in 2025. This growth is driven by the development and deployment of centralized high-complexity AST panels specifically tailored to emerging zoonotic pathogens, which reference labs alone can validate and offer due to their scale and specialized expertise. These panels support multiorganism resistance profiling required for public health surveillance, attracting high sample volumes from clinics and farms.

The vet research institutes segment is expected to register a CAGR of 8.69% during the forecast period, due to the creation of curated antimicrobial resistance biomarker libraries specific to understudied veterinary pathogens, enabling advanced genotype-phenotype correlation studies and fueling demand for research-grade AST platforms and custom analytical services.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America dominated the veterinary antimicrobial susceptibility testing market in 2025, accounting for 35.11% market share. The growth is supported by the prevalence of federally funded AMR veterinary research consortia that mandate participation in inter-laboratory AST proficiency testing programs, ensuring diagnostic quality benchmarking, accelerating uptake of standardized AST methods, and driving sustained high testing volumes across veterinary reference labs and academic partners.

Canada's market growth is driven by the implementation of a national veterinary antimicrobial sales reporting system that quantifies antimicrobial availability by animal species and informs stewardship strategies, enhancing data intelligence, regulatory compliance, and targeted AST utilization in animal health surveillance.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

Asia Pacific is emerging as the fastest-growing region with a CAGR of 9.42% from 2026 to 2034. This growth is augmented by the emergence of integrated livestock export compliance programs in countries like China and Australia that mandate AST data submission to meet stringent food safety standards for international meat and animal product shipments, driving routine laboratory testing and diagnostic infrastructure investments.

In Australia, the market growth is supported by the nation’s National Animal Health Diagnostics Business Plan, driving the establishment of a dedicated national AMR reference laboratory with standardized AST procedures and innovative diagnostics validation, strengthening diagnostic capacity, surveillance integration, and adoption of high-quality susceptibility testing across state and territory veterinary labs.

Europe Market Insights

Europe’s veterinary antimicrobial susceptibility testing market is experiencing strong growth due to the establishment and expansion of the European Antimicrobial Resistance Surveillance network in Veterinary Medicine, a dedicated EU-wide AMR monitoring system harmonizing AST methods, generating comparable resistance data, and guiding region-specific treatment guidelines.

In Germany, the market growth is driven by the nation’s GERM-Vet national resistance monitoring program, which coordinates 30 labs to systematically collect and test animal pathogen isolates against standardized antibiotic panels, generating robust resistance data that directly informs veterinarians’ treatment choices and increases routine AST utilization.

Latin America Market Insights

Latin America’s veterinary antimicrobial susceptibility testing market is growing steadily due to the increasing emphasis by export-oriented livestock producers on standardized AST as a prerequisite for international meat and poultry trade certifications, compelling diagnostic laboratories to adopt robust susceptibility testing protocols to meet stringent food safety and export requirements.

Argentina's veterinary antimicrobial susceptibility testing market is expanding rapidly due to the country’s enforcement of strict AMR regulations that prohibit critical antimicrobial uses in livestock, such as the ban on colistin and growth-promoting antibiotics under national AMR strategy policies, prompting producers to increasingly rely on formal AST data to justify therapeutic antibiotic use and comply with surveillance requirements.

Middle East and Africa Market Insights

The Middle East and Africa veterinary antimicrobial susceptibility testing market growth is propelled by the expansion of structured hands-on AMR diagnostic capacity building programs, such as advanced microbiology training workshops for East African veterinary lab personnel that strengthen regional AST competencies and elevate local testing quality and usage rates. This capacity development boosts the adoption of susceptibility testing across underserved veterinary networks.

South Africa's veterinary antimicrobial susceptibility testing market is witnessing growth driven by the strengthening of laboratory quality frameworks through accreditation by the South African National Accreditation System (SANAS), which compels veterinary diagnostic labs to achieve ISO/IEC 17025 standards for AST competency, thereby driving demand for advanced AST services.

Competitive Landscape

The global veterinary antimicrobial susceptibility testing market is moderately fragmented, with major diagnostics and life science firms securing notable shares through innovation, extensive AST portfolios, and broad laboratory networks. Leading players differentiate via automated platforms, standardized consumables, and integrated data solutions while collaborating with veterinary labs and surveillance agencies. Prominent companies include bioMérieux, Thermo Fisher Scientific, IDEXX Laboratories, BD, Bruker, and others, driving clinical adoption and market expansion.

Specific Diagnostics, Inc.: An emerging market player

Specific Diagnostics, a U.S.-based biotech innovator, is gaining traction in the veterinary antimicrobial susceptibility testing market with its rapid phenotypic AST system designed to deliver susceptibility results in reduced timeframes, addressing a key veterinary demand for same-day diagnostic turnaround. Its technology, recognized with FDA Breakthrough Device designation for rapid AST performance, is being integrated into broader diagnostic offerings, enhancing veterinary laboratory efficiency and antimicrobial stewardship capabilities.

List of Key and Emerging Players in Veterinary Antimicrobial Susceptibility Testing Market